Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.81
Delayed Data
As of Apr 01
 +0.03 / +1.69%
Today’s Change
1.53
Today|||52-Week Range
5.00
-1.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues7.4M2.7M3.7M1.4M
 
 
 
 
 
Cost of Goods Sold3.2M805.0K1.0M1.6M
 
 
 
 
 
Depreciation And Amortization828.0K800.0K790.0K--
 
 
 
 
 
Operating ExpensesGross Income3.3M1.1M1.9M-193.0K
 
 
 
 
 
General Expenses11.9M8.6M10.1M8.9M
 
 
 
 
 
Research And Development8.2M7.1M8.1M6.5M
 
 
 
 
 
Total Operating Expenses15.9M10.2M11.9M10.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-7.6M-8.2M-9.0M
 
 
 
 
 
Interest Expense On Debt915.0K874.0K938.0K1.4M
 
 
 
 
 
Other Expenses2.1M2.1M1.0M2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-6.1M-8.0M-8.5M
 
 
 
 
 
Net Income-7.3M-6.1M-8.0M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS92.7M92.8M93.0M--
 
 
 
 
Shares To Calculate EPS Diluted92.7M92.8M93.0M--
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.07-$0.09-$0.09
 
 
 
 
 
EPS Diluted-$0.08-$0.07-$0.09-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account